SPY761.84+1.59%QQQ694.76+2.96%BTC/USD74,343.07+0.88%DIA524.21+0.48%GLD365.69−0.99%TLT80.86−0.02%
BenzingaPremium Services
Premium Services

Stock Trading Ideas

EXCLUSIVE: Jensen Huang Drama Puts Q3 Financials on Backburner, Expert Says ‘No One Cares About Their Record Revenues’
EXCLUSIVE: Jensen Huang Drama Puts Q3 Financials on Backburner, Expert Says ‘No One Cares About Their Record Revenues’
Nvidia’s Earnings Day Is ‘Earnings Day for Your 401(k).’ Here’s Why
Nvidia’s Earnings Day Is ‘Earnings Day for Your 401(k).’ Here’s Why
Stock of the Day: Did Rocket Lab Breakout Yesterday?
Stock of the Day: Did Rocket Lab Breakout Yesterday?
Nvidia’s Earnings Day Is ‘Earnings Day for Your 401(k).’ Here’s Why
Nvidia’s Earnings Day Is ‘Earnings Day for Your 401(k).’ Here’s Why
Stock of the Day: Did Rocket Lab Breakout Yesterday?
Stock of the Day: Did Rocket Lab Breakout Yesterday?
EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat
EXCLUSIVE: Lilly, Gilead Face Near-Term Drug Pricing Risks As Washington Turns Up Heat
CoreWeave's AI Boom Splits Wall Street: One Analyst Sees a Hurricane, Another Sees a Turning Point
CoreWeave's AI Boom Splits Wall Street: One Analyst Sees a Hurricane, Another Sees a Turning Point

Trading Ideas Recent News

Legence Stock Soars: What's Going On?
Legence Stock Soars: What's Going On?
Legence shares are trading higher Wednesday, buoyed by strength in the AI trade ahead of the company's Q3 earnings report on Thursday.
ServiceNow Stock Climbs: What's Going On?
ServiceNow Stock Climbs: What's Going On?
ServiceNow Inc. (NYSE: NOW) shares are rising Wednesday as a tech-led rebound lifts software stocks. Here's what you should know.
Michael Burry Says Jensen’s Affair Won’t Sink Nvidia, But Regulators Might
Michael Burry Says Jensen’s Affair Won’t Sink Nvidia, But Regulators Might
Michael Burry says Nvidia’s scandal could intensify antitrust and China scrutiny, weakening its advantage.
AI Stocks Jump: Here's What You Should Know
AI Stocks Jump: Here's What You Should Know
Shares of Sharon Holdings, IREN, Galaxy Digital and Applied Digital are rising Wednesday as CoreWeave's earnings eased AI-sector jitters.
Firefly Aerospace Analysts Boost Their Forecasts Following Better-Than-Expected Q3 Results
Firefly Aerospace Analysts Boost Their Forecasts Following Better-Than-Expected Q3 Results
Firefly Aerospace beats Q3 estimates, raises 2026 outlook; shares jump 10%. B. Riley lifts target to $54, Barclays to $35.
These Analysts Cut Their Forecasts On Stubhub After Weak Q3 Results
These Analysts Cut Their Forecasts On Stubhub After Weak Q3 Results
StubHub missed Q3 EPS and revenue estimates; shares fell 1.5%. Evercore and JPMorgan cut price targets to $13 and $8.
Gossamer Bio Analysts Slash Their Forecasts Following Q3 Results
Gossamer Bio Analysts Slash Their Forecasts Following Q3 Results
Gossamer Bio missed Q3 loss estimates but beat sales forecasts; shares fell 4.7% as analysts cut price targets following its seralutinib NDA filing.
These Analysts Lower Their Forecasts On Rigetti Computing After Downbeat Q3 Results
These Analysts Lower Their Forecasts On Rigetti Computing After Downbeat Q3 Results
Rigetti missed Q3 FY26 estimates, with revenue down 28% year over year; shares fell 5%. Analysts cut price targets but kept Buy ratings.
These Analysts Cut Their Forecasts On BridgeBio Oncology After Q3 Results
These Analysts Cut Their Forecasts On BridgeBio Oncology After Q3 Results
BridgeBio Oncology beat Q3 loss estimates, shares jumped 18%, while analysts cut price targets to $9 and $15.
Short Interest Powder Kegs: 10 Stocks Bears Cannot Quit Buying
Short Interest Powder Kegs: 10 Stocks Bears Cannot Quit Buying
Venture Global tops heavily shorted stocks at 90.11% of float, with Sunrun, Ondas, Kohl's and Under Armour also on the list.
Palisade Bio Analysts Slash Their Forecasts After Q3 Results
Palisade Bio Analysts Slash Their Forecasts After Q3 Results
Palisade Bio missed Q3 loss estimates at 7¢/share. Shares rose 3.1% as analysts cut price targets; ASCENTRA trials advance.
These Analysts Boost Their Forecasts On Carlsmed After Strong Q3 Results
These Analysts Boost Their Forecasts On Carlsmed After Strong Q3 Results
Carlsmed beats Q3 estimates, raises FY2026 sales guidance to $78M-$80M, and shares jump 19.5% as analysts lift price targets.
This Zebra Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
This Zebra Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Analysts initiated coverage: Buy ratings for ZBRA and GLW, Overweight for CDNA, and Hold ratings for GWRE and ST, with price targets issued.
This Apple Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
This Apple Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Analysts upgraded RSG, AAPL, MRCY, DK and DRTS, revising price targets, including AAPL to $425 and DRTS to $22.
Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved